Septerna (SEPN) Profit After Tax (2023 - 2026)
Septerna (SEPN) recorded quarterly Profit After Tax of -$8.6 million in Q1 2026, up 20.03% quarter-over-quarter from -$10.8 million in Q4 2025, and up 59.78% on a YoY basis from -$5.4 million in Q1 2025.
Septerna (SEPN) Profit After Tax (2023 - 2026) Analysis & Trends
Septerna's Profit After Tax history runs 4 years deep, the most recent figure standing at -$8.6 million for Q1 2026.
- In Q1 2026, Profit After Tax rose 59.78% year-over-year to -$8.6 million; the TTM figure through Mar 2026 stood at -$36.1 million (up 54.4% YoY), while the FY2025 annual figure was -$48.9 million, up 31.89% from the prior year.
- Profit After Tax was -$8.6 million for Q1 2026 at Septerna, up from -$10.8 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $34.9 million in Q4 2023 to a low of -$24.8 million in Q2 2025.
- Historically, Profit After Tax has averaged -$9.6 million across 4 years, with a median of -$14.1 million in 2024.
- The sharpest annual moves came in 2024 and 2025: Profit After Tax slumped 159.23% in 2024, then soared 139.82% in 2025.
- A 4-year view of Profit After Tax shows it stood at $34.9 million in 2023, then slumped by 159.23% to -$20.7 million in 2024, then surged by 47.75% to -$10.8 million in 2025, then grew by 20.03% to -$8.6 million in 2026.
- The last three Profit After Tax figures came in at -$8.6 million (Q1 2026), -$10.8 million (Q4 2025), and $8.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 30.90 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.63 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -14.46 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -753,254.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.03 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -56.74 Mn |
| 10 | Septerna | 1.62 Bn | 1.62 Bn | - | -8.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.64 Mn |
| Dec 31, 2025 | -10.80 Mn |
| Sep 30, 2025 | 8.17 Mn |
| Jun 30, 2025 | -24.84 Mn |
| Mar 31, 2025 | -21.48 Mn |
| Dec 31, 2024 | -20.67 Mn |
| Sep 30, 2024 | -20.52 Mn |
| Jun 30, 2024 | -16.51 Mn |
| Mar 31, 2024 | -14.10 Mn |
| Dec 31, 2023 | 34.89 Mn |
| Sep 30, 2023 | -10.95 Mn |